QUOTED. 4 December. Eric Borin.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
“We've seen an overall step up in market demand for pre-filled syringes over the past three to four years.” – Eric Borin, president, BD Pharmaceuticals Systems
Click here for a free trial of Medtech Insight